BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 5762160)

  • 1. Continuous measurement of pentose phosphate pathway activity in erythrocytes. An ionization chamber method.
    Davidson WD; Tanaka KR
    J Lab Clin Med; 1969 Jan; 73(1):173-80. PubMed ID: 5762160
    [No Abstract]   [Full Text] [Related]  

  • 2. [Significance and regulation of the pentosephosphate pathway in human erythrocytes. II. Experiments with glucose-6-phosphate dehydrogenase-deficient erythrocytes].
    Brand K; Arese P; Rivera M
    Hoppe Seylers Z Physiol Chem; 1970 Apr; 351(4):509-14. PubMed ID: 4392679
    [No Abstract]   [Full Text] [Related]  

  • 3. Metabolism of the hexose monophosphate shunt in glucose-6-phosphate dehydrogenase deficiency and closely interrelated reactions.
    Jacobasch G; Bleiber R; Schönian G
    Haematologia (Budap); 1982 Dec; 15(4):401-7. PubMed ID: 7186479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theoretical considerations and models of red and white cell pentose cycles.
    Hodges JM; Grümer HD
    Clin Chem; 1973 Mar; 19(3):330-7. PubMed ID: 4689104
    [No Abstract]   [Full Text] [Related]  

  • 5. The influence of transplantable Morris hepatoma on the pentose-phosphate cycle in rat erythrocytes.
    Warchol T
    Ann Med Sect Pol Acad Sci; 1975; 20(1):39-46. PubMed ID: 166528
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of methylene blue on the pentose phosphate pathway in erythrocytes of monkeys infected with Plasmodium knowlesi.
    Barnes MG; Polet H
    J Lab Clin Med; 1969 Jul; 74(1):1-11. PubMed ID: 4978077
    [No Abstract]   [Full Text] [Related]  

  • 7. Factors affecting pentose phosphate pathway activity in human red cells.
    Davidson WD; Tanaka KR
    Br J Haematol; 1972 Sep; 23(3):371-85. PubMed ID: 5080355
    [No Abstract]   [Full Text] [Related]  

  • 8. Red cell metabolism in the premature infant. II. The pentose phosphate pathway.
    Oski FA
    Pediatrics; 1967 May; 39(5):689-95. PubMed ID: 6026872
    [No Abstract]   [Full Text] [Related]  

  • 9. The effect of o-salicylate upon pentose phosphate pathway activity in normal and G6PD-deficient red cells.
    Worathumrong N; Grimes AJ
    Br J Haematol; 1975 Jun; 30(2):225-31. PubMed ID: 35
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pentose phosphate pathway metabolism by normal and glucose-6-phosphate dehydrogenase-deficient human red cell haemolysates.
    Sturman JA
    Clin Chim Acta; 1967 Nov; 18(2):245-8. PubMed ID: 4383831
    [No Abstract]   [Full Text] [Related]  

  • 11. [Glucose-6-phosphate dehydrogenase deficiency and other erythrocyte enzyme abnormalities].
    Pohl A; Blechschmidt E; Moser K
    Wien Klin Wochenschr; 1984 Jul; 96(14):542-8. PubMed ID: 6089445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Possible regulation on carbohydrate metabolism exerted by glucose-6-phosphate isomerase and glucose-6-phosphate dehydrogenase activity ratio during Bufo bufo development.
    Miranda M
    Acta Embryol Exp (Palermo); 1976; (1):3-14. PubMed ID: 820150
    [No Abstract]   [Full Text] [Related]  

  • 13. Pentose phosphate pathway activity of the chick embryo in ovo.
    Wenger E; Wenger BS; Kitos PA
    J Exp Zool; 1967 Nov; 166(2):263-70. PubMed ID: 6080553
    [No Abstract]   [Full Text] [Related]  

  • 14. [Regulatory factors in methylene blue catalysis in erythrocytes].
    Roigas H; Zoellner E; Jacobasch G; Schultze M; Rapoport S
    Eur J Biochem; 1970 Jan; 12(1):24-30. PubMed ID: 4392179
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanisms of methylene blue stimulation of the hexose monophosphate shunt in erythrocytes.
    Metz EN; Balcerzak P; Sagone AL
    J Clin Invest; 1976 Oct; 58(4):797-802. PubMed ID: 965487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of inorganic phosphate on erythrocyte pentose phosphate pathway activity.
    Sagone AL; Metz EN; Balcerzak SP
    Biochim Biophys Acta; 1972 Jan; 261(1):1-8. PubMed ID: 5012466
    [No Abstract]   [Full Text] [Related]  

  • 17. [Transformation of drug-sensitive erythropathy into chronic hemolytic anemia in glucose-6-phosphatedehydrogenase deficiency].
    Busch D; Boie K
    Acta Haematol; 1967; 37(4):206-16. PubMed ID: 4961853
    [No Abstract]   [Full Text] [Related]  

  • 18. Clinical, metabolic and molecular consequences of genetic disorders of the pentose phosphate pathway.
    Carson PE
    Proc R Soc Med; 1970 Feb; 63(2):175-6. PubMed ID: 4909475
    [No Abstract]   [Full Text] [Related]  

  • 19. [Importance of the study of glucose-6-phosphate dehydrogenase in clinical medicine].
    Seringe P; Kaplan JC; Rosa J; Hoeffel JC; Bertrand C
    Recenti Prog Med; 1968 Oct; 45(4):363-86. PubMed ID: 5755669
    [No Abstract]   [Full Text] [Related]  

  • 20. Inherited erythrocyte metabolic and membrane disorders.
    Brewer GJ
    Med Clin North Am; 1980 Jul; 64(4):579-96. PubMed ID: 6995724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.